Literature DB >> 19661544

Psoriasis induced or aggravated by drugs.

Franco Rongioletti1, Cristina Fiorucci, Aurora Parodi.   

Abstract

Drug ingestion may result in exacerbation of preexisting psoriasis, induction of psoriatic lesions on clinically uninvolved skin in patients with psoriasis, or precipitation of the disease. In view of their relationship to psoriasis, therapeutic agents may be classified as follows: (1) drugs with strong evidence for a causal relationship to psoriasis including lithium, beta blockers, and synthetic antimalarial drugs; (2) drugs with considerable number of studies but insufficient data to support induction or aggravation of the disease; (3) drugs occasionally reported to be associated with aggravation or induction. While focusing on the most common causative agents for drug induced/aggravated psoriasis, we discuss the controversies about the relationship between drugs and psoriasis and report our own experience at the Section of Dermatology, University of Genoa.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661544     DOI: 10.3899/jrheum.090227

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  13 in total

Review 1.  New insights in the immunologic basis of psoriasis.

Authors:  Kristine E Nograles; Batya Davidovici; James G Krueger
Journal:  Semin Cutan Med Surg       Date:  2010-03

2.  Metoprolol-induced Total Body Erythroderma.

Authors:  Jeffrey B Doyon; Kristina J Liu; Rebecca A Berman
Journal:  J Gen Intern Med       Date:  2016-10-19       Impact factor: 5.128

Review 3.  Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature.

Authors:  Brahim Azzouz; Aurore Morel; Lukshe Kanagaratnam; Emmanuelle Herlem; Thierry Trenque
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

Review 4.  Psoriasis genetics: breaking the barrier.

Authors:  Elisha D O Roberson; Anne M Bowcock
Journal:  Trends Genet       Date:  2010-08-06       Impact factor: 11.639

Review 5.  MicroRNAs in normal and psoriatic skin.

Authors:  Jing Xia; Weixiong Zhang
Journal:  Physiol Genomics       Date:  2013-12-10       Impact factor: 3.107

6.  Triggering drug use in patients with psoriasis: an investigative report from Turkey.

Authors:  Zerrin Ogretmen; Ulku Askin; Meliha Merve Hiz; Sibel Cevizci
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

7.  An epidemiological study on trigger factors and quality of life in psoriatic patients.

Authors:  Alert Xhaja; Entela Shkodrani; Silvan Frangaj; Loreta Kuneshka; Ermira Vasili
Journal:  Mater Sociomed       Date:  2014-06-21

8.  The role of LncRNA MALAT-1 and MiRNA-9 in Psoriasis.

Authors:  Azza M Elamir; Olfat G Shaker; Mohamed Hm El-Komy; Mai Mahmoud Sharabi; Nesreen M Aboraia
Journal:  Biochem Biophys Rep       Date:  2021-05-25

9.  Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis.

Authors:  Rashmi Gupta; Henri-Alexandre Michaud; Xue Zeng; Maya Debbaneh; Sarah T Arron; R Brad Jones; Christopher E Ormsby; Douglas F Nixon; Wilson Liao
Journal:  J Transl Med       Date:  2014-09-16       Impact factor: 5.531

Review 10.  The role of hormones in the pathogenesis of psoriasis vulgaris.

Authors:  Iulia Ioana Roman; Anne-Marie Constantin; Mihaela Elena Marina; Remus Ioan Orasan
Journal:  Clujul Med       Date:  2016-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.